{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"PK: Average Concentration at Steady State of LY3499446 in Combination with Erlotinib","groups":[{"description":"LY3499446 in combination with erlotinib orally.","id":"OG000","title":"LY3499446 Monotherapy and Erlotinib Phase 1"}],"populationDescription":"Zero participants were analyzed due to early termination of study.","reportingStatus":"POSTED","timeFrame":"Predose Cycle 1 Day 1 through Cycle 3 Day 1 (21 Day Cycles)","title":"Phase 1: PK: Average Concentration at Steady State of LY3499446 in Combination With Erlotinib","type":"SECONDARY"}